Pyxis Oncology, INC 8-K filings

Pyxis Oncology announced its full year 2023 financial results and provided a corporate update, highlighting progress in its clinical trials and a recent $50 million private placement.

Pyxis Oncology has appointed Santhosh Palani, Ph.D., CFA, to its Board of Directors, effective March 12, 2024.

Pyxis Oncology has successfully raised $50 million through a private placement to fund the development of its lead drug candidate and for general corporate purposes.